HbA1c in diagnosing and predicting Type 2 diabetes in impaired glucose tolerance: The Finnish Diabetes Prevention Study

Diabetic Medicine

Volumn 28, Issue 1, 2011, Pages 36-42

  Pajunen, P ^a   Peltonen, M ^a   Eriksson, J G ^a,b,c,d,e   Ilanne Parikka, P ^f,g   Aunola, S ^a   Keinanen Kiukaanniemi S ^h,i   Uusitupa, M ^j   Tuomilehto, J ^a,b,k   Lindstrom J ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c Vasa Central Hospital   (Finland)

^d FOLKHÄLSAN RESEARCH CENTER   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f TAMPERE UNIVERSITY HOSPITAL   (Finland)

^g Finnish Diabetes Association   (Finland)

^h UNIVERSITY OF OULU   (Finland)

ⁱ OULU UNIVERSITY HOSPITAL   (Finland)

^j UNIVERSITY OF EASTERN FINLAND   (Finland)

^k SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

more..

Author keywords

Diagnosis; Glycated haemoglobin; Impaired glucose tolerance; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FINLAND; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INTERMETHOD COMPARISON; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; PROSPECTIVE STUDY; RANDOMIZATION; SENSITIVITY AND SPECIFICITY; WORLD HEALTH ORGANIZATION;

ADULT; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; FEMALE; FINLAND; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; OVERWEIGHT; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 78650248795     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2010.03183.x     Document Type: Article

References (24)

1. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 2010; 33: S11-61.
2. The DECODE Study Group on behalf of the European Diabetes Epidemiology Group. Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. Diabetologia 1999; 42: 647-654.
3. Bartnik M, Ryden L, Malmberg K, Ohrvik J, Pyörälä K, Standl E et al. Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart. Heart 2007; 93: 72-77.
4. 1c in the Diabetes Control and Complications Trial. Diabetes Care 2002; 25: 275-278.
5. 1c assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 1327-1334.
6. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 2008; 93: 2447-2453.
7. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33: S62-69.
8. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.
9. Eriksson J, Lindström J, Valle T, Aunola S, Hämäläinen H, Ilanne-Parikka P et al. Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia 1999; 42: 793-801.
10. World Health Organization Study Group. Diabetes mellitus. World Health Organ Tech Rep Ser 1985; 727: 1-113.
11. 1c and diabetes diagnosis: The Rancho Bernardo Study. Diabetes Care 2010; 33: 101-103.
12. 1c and glucose levels in the general Dutch population. The New Hoorn Study Diabetes Care 2010; 33: 61-66.
13. Uusitupa M, Peltonen M, Lindström J, Aunola S, Ilanne-Parikka P, Keinänen-Kiukaanniemi S et al. Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study-secondary analysis of the randomized trial. PLoS One 2009; 4: e5656.
14. Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006; 368: 1673-1679.
15. Wong TY, Liew G, Tapp RJ, Schmidt MI, Wang JJ, Mitchell P et al. Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet 2008; 371: 736-743.
16. 1c measurement. Diabetes Care 2007; 30: 2399-2400.
17. 1c and fasting glucose criteria to diagnose diabetes among US adults. Diabetes Care 2010; 33: 95-97.
18. The DECODE Study Group on behalf of the European Diabetes Epidemiology Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 1999; 354: 617-621.
19. The DECODE Study Group on behalf of the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-h diagnostic criteria. Arch Intern Med 2001; 161: 397-405.
20. Balkau B, Hu G, Qiao Q, Tuomilehto J, Borch-Johnsen K, Pyöräläa K. Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study. Diabetologia 2004; 47: 2118-2128.
21. Qiao Q, Jousilahti P, Eriksson J, Tuomilehto J. Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up. Diabetes Care 2003; 26: 2910-2914.
22. Ilanne-Parikka P, Eriksson JG, Lindström J, Hämäläinen H, Keinänen-Kiukaanniemi S, Laakso M et al. Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort. Diabetes Care 2004; 27: 2135-2140.
23. 1c. Acta Diabetol 2000; 37: 1-7.
24. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization, 1999.